Michael Porter is the CEO of Covis Pharma, where they lead a global pharmaceutical platform focused on therapeutic solutions for patients with critical health conditions. With a strong background in finance and management, they previously held senior roles at Cerberus Capital Management, Sun Capital Partners, and AlixPartners, specializing in corporate turnaround and restructuring. Michael began their career as a Financial Analyst at Bank of America, successfully closing numerous high-yield transactions. They hold an MBA in International Finance from Columbia Business School and currently serve on the boards of Huxley Medical, Inc. and restor3d.
This person is not in the org chart
This person is not in any teams
This person is not in any offices